Abstracts of the 3rd annual meeting of the Hematology/Oncology Pharmacy Association (HOPA), June 14-16, 2007.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006402:Hematologic Diseases / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000628:therapy*
D000970:Antineoplastic Agents